Key facts
- Clair Health has raised $11.6 million in funding to develop a non-invasive wearable for hormone tracking.
- The device uses AI and 10 biosensors, including a novel biomagnetic sensor, to monitor hormonal changes.
- The wearable aims to provide insights into cycle irregularities, perimenopause, and hormonal fluctuations.
- The company utilizes voice-based onboarding and AI to analyze biomarkers and determine cycle phases.
- Clair Health plans to ship devices in November for $369, with a $9.99 monthly subscription.
Clair Health, a startup founded by Stanford graduates Jenny Duan and Abhinav Agarwal, has raised $11.6 million to develop a non-invasive wearable device focused on women's hormonal health. The company aims to provide users with insights into inflammation, bloating, energy levels, and cycle phases, addressing issues like cycle irregularities and perimenopause.
The funding round was led by Khosla Ventures, with participation from a16z speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, Anne Wojcicki, and Stephanie Coleman. Clair Health differentiates itself by using voice-based onboarding and proprietary AI to analyze voice biomarkers, allowing users to communicate symptoms in their own way.
The wearable device will feature 10 biosensors, including a novel biomagnetic sensor, to capture real-time hormonal insights, a capability the startup claims is currently unmet by existing devices like the Apple Watch or Pixel Watch. The company is also leveraging data partnerships with access to millions of electronic health records to build models for conditions such as endometriosis and PMDD.
Clair Health is currently in a closed beta testing phase and plans to begin shipping its devices in November. The product will be priced at $369, accompanied by a $9.99 monthly subscription fee. Investors like Mary Minno from Treehub highlight the startup's potential to offer actionable insights into hormonal health, moving beyond traditional methods like blood draws.